Adia Med Inc
Income Statement
| Line Item | FY2025 | FY2024 |
|---|---|---|
| Revenue | $700.5K | $6.4K |
| Cost of Revenue | $508.8K | $4.2K |
| Gross Profit | $191.7K | $2.2K |
| Gross Margin | 27.4% | 34.4% |
| Operating Expenses | ||
| Research & Development | $29.1K | $0 |
| SG&A Expense | $480.0K | $140.4K |
| Operating Income | $-366.5K | $-174.7K |
| Operating Margin | -52.3% | -2,739.0% |
| Interest Expense | — | — |
| Pretax Income | $-395.5K | $-181.1K |
| Income Tax Expense | $0 | $0 |
| Net Income | $-395.5K | $-181.1K |
| Net Margin | -56.5% | -2,838.0% |
| EPS (Basic) | $0.00 | $0.00 |
| EPS (Diluted) | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 93.6M | 91.7M |
| Shares Outstanding (Diluted) | 93.6M | 91.7M |
| Dividends Per Share | — | — |